Effects of experimental diabetes on aminopyrine metabolism in rats

References

• Agarwal M. K. Streptozotocin: mechanisms of action. FEBS Letters 1980; 120: 1–3
   PubMed Web of Science ®Google Scholar
• Andrews S. M., Griffiths L. A. The metabolism and disposition of [2-14C]diazepam in the streptozotocin-diabetic rat. Xenobiotica 1984; 14: 751–760
   PubMed Web of Science ®Google Scholar
• Brodie B. B., Axelrod J. The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological materials. The Journal of Pharmacology and Experimental Therapeutics 1950; 99: 171–184
   PubMed Web of Science ®Google Scholar
• Chawalit K., Sretarugsa P., Thithapandha A. Comparative effects of diabetogenic agents on hepatic drug metabolism. Drug Metabolism and Disposition 1982; 10: 81–86
   PubMed Web of Science ®Google Scholar
• Cook D. E., Past M. R. Drug metabolism in diabetic isolated perfused rat liver. Research Communications in Chemical Pathology and Pharmacology 1979; 24: 389–392
   PubMedGoogle Scholar
• Dajani R. M., Kayyali S. Y. The biotransformation of acetophenetidin in the alloxandiabetic rabbit. Comparative and General Pharmacology 1973; 4: 23–35
   Google Scholar
• Dixon R. L., Hart L. G., Fouts J. R. The metabolism of drugs by liver microsomes from alloxan-diabetic rats. The Journal of Pharmacology and Experimental Therapeutics 1961; 133: 7–11
   PubMed Web of Science ®Google Scholar
• Eacho P. I., Weiner M. Metabolism of p-nitroanisole and aniline in isolated hepatocytes of streptozotocin-diabetic rats. Drug Metabolism and Disposition 1980; 8: 385–389
   PubMed Web of Science ®Google Scholar
• Fass F. H., Carter W. J. Cytochrome P-450 mediated drug metabolism in the streptozotocin diabetic rat. Hormone and Metabolic Research 1980; 12: 706–707
   PubMed Web of Science ®Google Scholar
• Goromaru T., Noda A., Matuyama K., Iguchi S. Metabolism and excretion of aminopyrine in man. Chemical & Pharmaceutical Bulletin (Tokyo) 1976; 24: 1376–1383
   PubMed Web of Science ®Google Scholar
• Gram T. E., Wilson J. T., Fouts J. R. Some characteristics of hepatic microsomal systems which metabolize aminopyrine in the rat and rabbit. The Journal of Pharmacology and Experimental Therapeutics 1968; 159: 172–181
   PubMed Web of Science ®Google Scholar
• Iguchi S., Goromaru T., Noda A., Tsubone N. Excretion of 4-formylaminoantipyrine as a new metabolite of aminopyrine in experimental animals. Chemical & Pharmaceutical Bulletin (Tokyo) 1975; 23: 1889–1890
   PubMed Web of Science ®Google Scholar
• Imai Y., Ito A., Sato R. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. The Journal of Biochemistry 1966; 60: 417–428
   PubMed Web of Science ®Google Scholar
• Kametani T., Kitagawa K., Ikari N., Iwata T., Saito M., Yagi H. Studies on the syntheses of heterocyclic compounds. CXCV. The structure of a yellow substance formed by mild oxidation of aminopyrine. Chemical & Pharmaceutical Bulletin (Tokyo) 1967; 15: 1305–1308
   PubMed Web of Science ®Google Scholar
• Kato R., Tananaka A., Onoda K. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes. Biochemical Pharmacology 1971; 20: 447–458
   PubMed Web of Science ®Google Scholar
• Knorr L., Stolz F. Ueber das 4-amidoantipyrin. Justus Liebigs Annalen der Chemie 1897; 293: 58–69
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Morita M. Synthesis and antibacterial activity of antipyrine derivatives. III. decomposition and colorimetric determination of sulpyrine (sodium N-4-antipyrinylmethylaminomethanesulfonate). Yakugaku Zasshi 1962; 82: 50–56
   PubMedGoogle Scholar
• Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal 1953; 55: 416–421
   PubMed Web of Science ®Google Scholar
• Nishibayashi H., Sato R. On the reduced minus oxidized difference spectrum of P-450 in liver microsomes. The Journal of Biochemistry 1967; 61: 491–496
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. The Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Pederson T. C., Aust S. D. Aminopyrine demethylase, kinetic evidence for multiple microsomal activities. Biochemical Pharmacology 1970; 19: 2221–2230
   PubMed Web of Science ®Google Scholar
• Phillips A. H., Langdon R. G. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. The Journal of Biological Chemistry 1962; 237: 2652–2660
   PubMed Web of Science ®Google Scholar
• Price V. F., Jollow D. J. Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. The Journal of Pharmacology and Experimental Therapeutics 1982; 220: 504–513
   PubMed Web of Science ®Google Scholar
• Reinke L. A., Stohs S. J., Rosenberg H. Altered activity of hepatic mixed-function monooxygenase enzymes in streptozotocin-induced diabetic rats. Xenobiotica 1978; 8: 611–619
   PubMed Web of Science ®Google Scholar
• Shimeno H., Yoshimura H. Possible implication of aldehyde metabolite in aminopyrine allergy. Xenobiotica 1972; 2: 461–468
   PubMed Web of Science ®Google Scholar
• Takesue S., Omura T. Purification and properties of NADH-cytochrome b5 reductase solubilized by lysosomes from rat liver microsomes. The Journal of Biochemistry 1970; 67: 267–276
   PubMed Web of Science ®Google Scholar
• Weber W. W. N-Acetyltransferase (mammalian liver). Methods in Enzymology, H. Tabor, C. W. Tabor. Academic Press, New York 1971; Vol. 17B: 805–811
   Google Scholar
• Yoshimura H., Shimeno H., Tsukamoto H. Metabolism of drugs. LXXI. the study on aminopyrine metabolism. Yakugaku Zasshi 1970; 90: 1406–1411
   PubMed Web of Science ®Google Scholar